Lori Hazlehurst

Modulation Therapeutics, Inc.

$1,674,270

Attributed

$3,605,194

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY2013–23

$2M$1.5M$1M$500K$0

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$3,605,194 · 5

By mechanism

R44$2,434,274 · 1

R41$882,619 · 3

R43$288,301 · 1

Top collaborators

Most similar at Modulation Therapeutics, Inc.

Same institution · by research overlap

Werner Geldenhuys$2,374,551
Karen Hayes$1,000,000
Priyesh Jain$52,067
Rajesh R Nair$72,939
Karen E Hayes$1,245,154

Others in their field

Top investigators on “In Vivo”

David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
Dennis R. Burton · Scripps Research Institute$212,708,174
Mark S Klempner · Tufts Medical Center$128,021,180
Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200

Research focus

In VivoCellsMouse ModelDoseMalignant NeoplasmsLegal PatentNovel TherapeuticsPathway InteractionsHalf-LifeClinical TrialsResponseComplexCd44 GeneCyclic PeptidesCell DeathPhase I Clinical TrialsMultiple MyelomaRelapseDesignBaseIn Vivo ModelResistanceGrantHour